Product Information |
|
Registration Number |
BR-1462
|
Generic Name |
Ocrelizumab
|
Brand Name |
Ocrevus
|
Dosage Strength |
300 mg/10 ml (30 mg/ml)
|
Dosage Form |
Concentrate for Solution for
Intravenous Infusion.
|
Classification |
Prescription Drug (RX)
|
Packaging |
15 mL colorless USP/Ph. Eur./JP Type I glass vial with a 20 mm rubber stopper laminated with fluororesin film, which is crimped with a 20 mm aluminum seal fitted with a plastic flip-off cap
|
Pharmacologic Category |
Selective Immunosuppresant
|
Manufacturer |
Roche Diagnostics GmbH
|
Country of Origin |
Germany
|
Trader |
|
Importer |
Roche (Philippines), Inc.
|
Distributor |
|
Application Type |
Monitored Release
|
Issuance Date |
22 December 2023
|
Expiry Date |
22 December 2028
|